In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.
GlobalData on MSN16h
FDA approves early feasibility study of Valcare’s transcatheter deviceThe US Food and Drug Administration (FDA) has granted approval for Valcare Medical’s investigational device exemption ...
Medtronic VP Jason Fontana offered advice for other device developers who might one day be looking for their own NCA.
Ali, H. , Ghaysaa, H. , Jaafar, W. and Malek, M. (2025) Ischemic Stroke Following Coronary Angiography: A Case Report. Case Reports in Clinical Medicine, 14, 123-129. doi: 10.4236/crcm.2025.143016 .
The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent.
Among patients with isolated systolic hypertension and frailty, antihypertensive therapy is associated with improved outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback